UPDATE: In a shocking turn of events, Los Angeles Angels president John Carpino declared that the late pitcher Tyler Skaggs was a “drug addict and a drug dealer” during the final day of testimony in a wrongful-death civil trial. This explosive statement, made on October 27, 2023, intensifies the ongoing legal battle as Skaggs’ family seeks $118 million in damages, claiming negligence on the part of the Angels.
Carpino’s remarks came as he and senior vice president of finance Molly Jolly faced cross-examination, reaffirming their lack of knowledge regarding Skaggs’ and employee Eric Kay’s drug issues. Kay was convicted in federal court in 2022 for supplying the fentanyl-laced pill that resulted in Skaggs’ death on July 1, 2019.
“Throughout this case of the last six years, the Angels have taken the position that Tyler Skaggs is the bad guy,” lead plaintiffs attorney Rusty Hardin pressed Carpino. “That’s not the position,” Carpino retorted, asserting that both Skaggs and Kay were involved in drug use and distribution.
The trial, which has garnered widespread attention, has seen multiple players admit to receiving pills from Skaggs and Kay. However, no evidence has confirmed that Skaggs sold drugs. The plaintiffs argue that the Angels failed to monitor Kay, placing Skaggs at risk.
“Had I known about Kay’s issues, I would have reported them immediately,” Jolly testified, emphasizing the need for transparency in the organization.
As the case unfolds, the emotional weight is palpable. Skaggs’ family is fighting for accountability, claiming the Angels’ negligence contributed to his tragic death. Jurors could begin deliberations as early as this afternoon, with closing arguments scheduled for October 30, 2023.
This trial has revealed conflicting testimonies, including insights from addiction expert Dr. Elie Aoun, who stated that Skaggs’ addiction persisted until his death. The Angels’ defense has argued that Skaggs’ choices led to his demise, while plaintiffs stress the organization’s responsibility in monitoring employee conduct.
As the legal battle intensifies, the implications for the Angels and Major League Baseball are significant. The outcome of this trial may lead to greater scrutiny of player health and organizational accountability within the sports industry.
Stay tuned as more developments emerge from the courtroom. This case not only impacts the Angels but also shines a light on larger issues of drug use and management within professional sports.
